Episode summary

BI Weekend: Target, Home Depot, Retail Earnings | Bloomberg Intelligence

Bloomberg Intelligence · · Hosts: Paul Sweeney, Lisa Mateo · Guests: Mary Ross Gilbert, Deborah Aitken, Jennifer Bartashus, Drew Reading, Matt Henricksson, Madison Muller, Ana Davies

BI Weekend: Target, Home Depot, Retail Earnings | Bloomberg Intelligence – Bloomberg Intelligence

Summary

TJX was presented as the clearest winner in the batch of retail earnings. A guest analyst said the off-price chain is executing exceptionally well, with strength across income groups and categories, better buying, and guidance raised for both sales and margins. The discussion emphasized that TJX’s sourcing flexibility has helped it navigate tariffs, while its digital business remains small but still meaningful, with e-commerce now part of the model outside HomeGoods.

The conversation on Estee Lauder was more cautious. A guest analyst said the beauty company is still dealing with heavy inventory, weak travel retail, and ongoing pressure in Asia, even as some markets and categories improve. She said recent analyst upgrades reflected easier comparisons and hope for better execution under newer leadership, but she still sees a bumpy path to restoring margins.

Target, Home Depot and Medtronic were all framed as companies trying to balance tariff pressure with softer demand. Target’s internal CEO pick signaled continuity rather than a reset, Home Depot said consumers are favoring smaller repair projects over big remodels, and Medtronic’s investor pressure from Elliott is aimed at unlocking growth and efficiency. The show also highlighted Novo Nordisk’s price cuts on Ozempic and Wegovy, and BNEF’s view that sustainable aviation fuel is growing fast but remains far too costly and constrained to meet ambitious targets.

Key takeaways

  • TJX is outperforming because it can buy better, price well, and keep traffic strong across income groups, according to a guest analyst.
  • Estee Lauder still faces inventory overhangs and travel-retail weakness, even as the guest analyst sees some share gains and easier comparisons ahead.
  • Target’s internal CEO appointment suggests continuity, while the guest analyst said investors were hoping for a more disruptive turnaround.
  • Home Depot is seeing consumers defer kitchen, bath and flooring projects in favor of smaller maintenance and repair jobs because of higher rates.
  • Medtronic’s new board additions tied to Elliott are meant to improve execution and support growth in products like pulse field ablation.
  • BNEF’s analyst said sustainable aviation fuel production is rising sharply, but cost and feedstock limits make long-term targets hard to hit.

Notable quotes

“TJX is hitting it out of the park. This is a company that just executes seamlessly and consistently”

— A speaker on Bloomberg Intelligence at 1:46

“Target's digital strategy has been doing pretty well. Um, they've done a they've made a conscious decision to not go head-to-head with Walmart and Target”

— A speaker on Bloomberg Intelligence at 21:30

“Home Depot has done well to diversify their sourcing over the last several years. They get about 50% of their products from the US”

— A speaker on Bloomberg Intelligence at 24:16

“the main challenge is cost. Uh it's very costly. So, the cheapest way to make these fuels is kind of what I've been describing”

— A speaker on Bloomberg Intelligence at 42:14

How the episode opens

Bloomberg Audio Studios podcasts radio news. This is Bloomberg Intelligence with Paul Sweeney. — The real our performance has been the US corporate high yield. These are two big time blue chip companies. One person's chaos is another person's animal spirits.

Breaking market headlines — And corporate news from across the globe. — Our view is that the economy is slowing down. There is the possibility of a death spiral. — Both quantum computing and AI are going to power the future. — People are just buying everything with tech.

Bloomberg Intelligence — With Paul Sweeney — On Bloomberg Radio, YouTube, and Bloomberg Originals. — I'm Paul Sweeney. — And I'm Lisa Matteo filling in on Bloomberg Intelligence. — On today's Bloomberg Intelligence Show, we dig inside the big business stories impacting Wall Street and the global markets. Each and every week, we provide in-depth research and data on some of the 2,000 companies and 130 industries our analysts cover worldwide.

Today, we'll look at why retailer Target is naming an insider as its next chief executive officer. — Plus, we'll look at why the Danish drug maker Novo Nordisk is slashing the cost of its weight loss drug OMIC. — But first, we begin with the earnings from TJX Companies.

This week, the off-pric retailer raised its fullear guidance and reported second quarter earnings that beat analyst projections. It's a sign that shoppers are currently turning toward discounters due to economic uncertainty. — For more, guest host Alexis Christopherus and I were joined by Mary Ross Gilbert, Bloomberg Intelligence senior retail equity analyst. We first asked Mary for her take on the company's results.

TJX is hitting it out of the park. This is a company that just executes seamlessly and consistently. Something in retail that's very, very difficult to do.

From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →

Topics

  • retail earnings
  • home improvement earnings
  • luxury goods earnings
  • medtech earnings
  • renewable fuels

Companies and tickers mentioned

  • TJX
  • EL
  • TGT
  • HD
  • MDT
  • NVO
  • TJX Companies
  • Estée Lauder
  • Target
  • Home Depot
  • Medtronic
  • Novo Nordisk

Watch the episode

Watch “BI Weekend: Target, Home Depot, Retail Earnings | Bloomberg Intelligence” on YouTube

Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.

More from Bloomberg Intelligence

All Bloomberg Intelligence episodes →

Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.